Mike is a Director of Inova Personalized Health Accelerator. He is responsible for identifying and investing in all IPHA companies and expediting their achievement of value creating milestones.
As a healthcare technology CEO, Mike raised $125 million in capital and drove shareholder returns that ranged from 4x to 80x, including one IPO and one acquisition. Mike was most recently the founder and CEO of Appian Medical, a digital health firm that served the sleep apnea market. Previously, Mike was CEO of iSonea Ltd (ASX:ISN), a publicly traded global, mobile health app developer and medical device manufacturer in the respiratory disease market, where he increased the company’s market capitalization from $4MM to $250MM.
Earlier in his career, Mike was President and CEO of Sleep Solutions, a VC-backed medical device manufacturer, EVP of Sales and Marketing for National Sleep Technologies (NST, acquired by GE Medical), and Vice President of Sales at Patient InfoSystems (NASDAQ: PATI). Mike began his career in sales and marketing at Merck and GlaxoWellcome.
He is currently a member of the Board of Directors for Circadiance LLC, a specialty CPAP mask manufacturer and is a former board member of AdvaMed, the global medical device association.
Mike graduated from Cornell University with a degree in Microbiology.
The Paradox of Today’s Early Stage Health Tech Investing Trend Read More
Partnership Will Provide Inova Patients with Precision Prenatal and Postpartum Care Babyscripts, Inc., the leading virtual care platform for... Read More
January 23, 2019 Inova Personalized Health Accelerator Invests in DeepLook, Inc. Fairfax, Virginia— A new digital technology designed to... Read More